Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Dinney

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 22, 2005
Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathwaysJai-Hyun Kim, Tomasz Tuziak, Limei Hu, et al.
Cancer Metastasis Reviews|December 17, 2009
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancerDavid J McConkey, Woonyoung Choi, Lauren Marquis, et al.
European Urology Focus|February 12, 2018
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) TestShizhen Zhang, Yan Wang, Jolanta Bondaruk, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerAlexandre R Zlotta, Samuel M Cohen, Colin Dinney, et al.
Plos One|January 19, 2012
p63 expression defines a lethal subset of muscle-invasive bladder cancersWoonyoung Choi, Jay B Shah, Mai Tran, et al.
European Urology|September 7, 2015
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerDavid J McConkey, Woonyoung Choi, Yu Shen, et al.
The Journal of Biological Chemistry|December 15, 2012
The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al.
Clinical Genitourinary Cancer|January 18, 2022
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial CarcinomaMehrad Adibi, Barrett McCormick, Minas P Economides, et al.
Urologic Oncology|January 19, 2020
Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomesVikram M Narayan, Mohamed A Seif, Amy H Lim, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 22, 2005
Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathwaysJai-Hyun Kim, Tomasz Tuziak, Limei Hu, et al.
Cancer Metastasis Reviews|December 17, 2009
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancerDavid J McConkey, Woonyoung Choi, Lauren Marquis, et al.
European Urology Focus|February 12, 2018
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) TestShizhen Zhang, Yan Wang, Jolanta Bondaruk, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerAlexandre R Zlotta, Samuel M Cohen, Colin Dinney, et al.
Plos One|January 19, 2012
p63 expression defines a lethal subset of muscle-invasive bladder cancersWoonyoung Choi, Jay B Shah, Mai Tran, et al.
European Urology|September 7, 2015
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerDavid J McConkey, Woonyoung Choi, Yu Shen, et al.
The Journal of Biological Chemistry|December 15, 2012
The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al.
Clinical Genitourinary Cancer|January 18, 2022
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial CarcinomaMehrad Adibi, Barrett McCormick, Minas P Economides, et al.
Urologic Oncology|January 19, 2020
Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomesVikram M Narayan, Mohamed A Seif, Amy H Lim, et al.
Pageof 6